|
Docetaxel+Carboplatin+trastuzumab+Parstuzumab Clinical Trials
1 actively recruiting trial
No change since May 2026
Also known as: TCbHP regimen
Pipeline
Phase 2: 1
Top Sponsors
- Henan Cancer Hospital1
Indications
- HER2-positive Breast Cancer1
- Breast Cancer1
- Cancer1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.